MedTrace Logo

Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF Ratio

NCT06403722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2024-05-08

No results posted yet for this study

Summary

Retrospective cohort study that evaluated 190 subjects admitted with diagnosis of hypertensive disorder of pregnancy, between 24 and 36 6/7 weeks, with an sFlt-1/PlGF index greater than or equal to 110. Data were collected on their clinical course prior to termination of pregnancy, using the last reported sFlt-1/PlGF ratio value to classify the population into four cohorts: values between 110-205, between 206 and 654, between 655 and 999 and greater than 1000.

Conditions

  • Hypertension in Pregnancy

Interventions

DIAGNOSTIC_TEST

Standard of care

No intervention. Clinical evolution was recorded, looking for perinatal complications.

Sponsors & Collaborators

  • Saint Thomas Hospital, Panama

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2023-12-30
Completion
2024-01-30

Countries

  • Panama

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06403722 on ClinicalTrials.gov